Accelerate drug development           Proteomics technology           
 

 Clients and Partners

IBI works with commercial and research organizations at the forefront of drug development and proteomics.

Partial Client List
Analysis Services
Bayer, Pharmaceutical Division
R. W. Johnson Pharmaceutical
Research Institute
Millenium Pharmaceuticals, Inc.
Merck
Wyeth-Ayerst Research
Monsanto Corporation
Glaxo-Wellcome
Genencor, Inc.
NIH-NICHD
Ortho-Clinical Diagnostics
Biosite
Scios
Amgen
UMDNJ

 
Research and Development
Arizona Disease Control
Research Commission
Biacore, AB (Upsala, Sweden)
Sequel Genetics
Phylomed Corporation
TGen

Corporate Partners
IBI is actively engaged with organizations whose tech platform can benefit or extend IBI's proprietary technologies.

Bruker Daltonics
Bruker Daltonics is a leading manufacturer of mass spectrometry instruments and accessories for pharmaceutical, biochemical and chemical research. IBI utilizes equipment made by Bruker Daltonics in its internal operations, and within its technology access offerings.

Beavis Informatics
Beavis Informatics was founded to provide innovative products and services to companies who are engaged in the new Systems Biology marketplace. Through this partnership, Beavis Informatics Ltd. will develop a proprietary informatics system suited for IBI's high-throughput MASSAY system and technologies. see press release >>

Explore this section
Management
Clients and Partners

Related information
Biomarker discovery
Proteomics technology
Publications
Request information

Home | Sitemap | Directions | Literature